- Home
- AAM vs PACB Comparison
AAM vs PACB Comparison
Compare AAM & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAM
- PACB
- Stock Information
- Founded
- AAM 2024
- PACB 2000
- Country
- AAM United States
- PACB United States
- Employees
- AAM N/A
- PACB N/A
- Industry
- AAM
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- AAM
- PACB Industrials
- Exchange
- AAM Nasdaq
- PACB Nasdaq
- Market Cap
- AAM 460.0M
- PACB 381.5M
- IPO Year
- AAM 2024
- PACB 2010
- Fundamental
- Price
- AAM $10.50
- PACB $1.27
- Analyst Decision
- AAM
- PACB Buy
- Analyst Count
- AAM 0
- PACB 7
- Target Price
- AAM N/A
- PACB $1.90
- AVG Volume (30 Days)
- AAM 14.5K
- PACB 5.1M
- Earning Date
- AAM 01-01-0001
- PACB 11-06-2025
- Dividend Yield
- AAM N/A
- PACB N/A
- EPS Growth
- AAM N/A
- PACB N/A
- EPS
- AAM 0.32
- PACB N/A
- Revenue
- AAM N/A
- PACB $156,110,000.00
- Revenue This Year
- AAM N/A
- PACB $6.15
- Revenue Next Year
- AAM N/A
- PACB $15.68
- P/E Ratio
- AAM $32.62
- PACB N/A
- Revenue Growth
- AAM N/A
- PACB N/A
- 52 Week Low
- AAM $9.98
- PACB $0.85
- 52 Week High
- AAM $10.79
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- AAM 55.61
- PACB 49.19
- Support Level
- AAM $10.48
- PACB $1.15
- Resistance Level
- AAM $10.51
- PACB $1.32
- Average True Range (ATR)
- AAM 0.01
- PACB 0.07
- MACD
- AAM 0.00
- PACB 0.00
- Stochastic Oscillator
- AAM 85.71
- PACB 60.00
About AAM AA Mission Acquisition Corp. Class A Ordinary Shares
AA Mission Acquisition Corp is a blank check company.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.